— Know what they know.
Not Investment Advice

PRTT OTC

Protect Pharmaceutical Corporation
1W: +2.4% 1M: -5.6% 3M: +126.7% YTD: +84.8% 1Y: -28.6% 3Y: -70.7% 5Y: -70.2%
$0.17
+0.00 (+0.00%)
 
OTC · Industrials · Airlines, Airports & Air Services · Tech Score Sell · Power 44 · $9.8M mcap · 57M float · 0.044% daily turnover · Short 54% of daily vol

Balance Sheet Trends

Total Assets
$418M +14.0% ▲
5Y CAGR: +394.8%
Total Liabilities
$85M -5.6% ▼
5Y CAGR: +321.1%
Shareholders Equity
$333M +20.4% ▲
Cash & Investments
$74M +13.6% ▲
5Y CAGR: +1139.2%
Total Debt
$4M +1.0% ▲
Net Debt
-$14M +4.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$74K$40M$1M$18M$18M
Short-Term Investments$0$38M$45M$47M$56M
Cash & ST Investments$74K$77M$47M$65M$74M
Net Receivables$0$25M$48M$64M$68M
Inventory$0$51M$83M$83M$118M
Other Current Assets$0$0$0$0$0
Total Current Assets$74K$154M$178M$213M$260M
Property, Plant & Equip.$20M$172M$150M$142M$139M
Goodwill & Intangibles$0$29M$5M$4M$5M
Long-Term Investments$140K$12M$12M$7M$14M
Other Non-Current Assets$0$0$0$4M$0
Total Non-Current Assets$20M$213M$167M$154M$158M
Total Assets$20M$366M$344M$366M$418M
— Liabilities —
Accounts Payable$2K$500K$3M$4M$5M
Short-Term Debt$0$12M$3M$4M$4M
Deferred Revenue$0$66M$58M$24M$18M
Other Current Liabilities$48K$82M$51M$20M$17M
Total Current Liabilities$50K$161M$114M$90M$85M
Long-Term Debt$14M$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$14M$0$0$0$0
Total Liabilities$14M$161M$114M$90M$85M
— Equity —
Common Stock$275K$5M$5M$6M$6M
Retained Earnings-$4M$200M$225M$271M$326M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$6M$206M$230M$276M$333M
Total Liabilities & Equity$20M$366M$344M$366M$418M
— Key Metrics —
Total Debt$14M$12M$3M$4M$4M
Net Debt$14M-$28M$1M-$14M-$14M
Total Investments$140K$50M$58M$54M$70M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms